Sign in to view content

A Phase 2 Safety and Efficacy Trial of AU-011, a Virus-Like Drug Conjugate, With Dose Escalation and Randomized Masked Expansion in Uveal Melanoma

Prithvi Mruthyunjaya, MD, MHS

Video
Published 2021

Related

Multiplex Ligation Probe Amplification (MLPA) Assay for Metastatic Prognosis in Uveal Melanoma: Results of A Multi-Center International Collaboration
Tara A. McCannel, MD, PhD
Updates from the Field
2019
Canadian Treat-and-Extend Trial With Ranibizumab in nAMD Patients: CANTREAT 36-Month Extension Results
Peter J. Kertes, MD, FRCS(C)
Annual Meeting Talks
2020
Baseline Factors Associated With 1-Year Outcomes in Phase III Comparison of SB11 (Approved Ranibizumab Biosimilar) With Reference Ranibizumab in nAMD
Neil M. Bressler, MD
Annual Meeting Talks
2022

Category: Ocular Oncology

See more